Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

T-cells immune response controls the high incidence of adenovirus infection in adult allogenic hematopoietic transplantation recipients.

Sánchez-Céspedes J, Marrugal-Lorenzo JA, Martín-Gandul C, Rodríguez-Torres N, Montero-Mateos E, Serna-Gallego A, Escamilla-Gómez V, Merino L, Espigado I, Pachón J, Pérez-Simón JA, Aguilar-Guisado M.

Haematologica. 2020 Jan 23. pii: haematol.2019.240101. doi: 10.3324/haematol.2019.240101. [Epub ahead of print] No abstract available.

2.

A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients.

Gudiol C, Arnan M, Aguilar-Guisado M, Royo-Cebrecos C, Sánchez-Ortega I, Montero I, Martín-Gandul C, Laporte-Amargós J, Albasanz-Puig A, Nicolae S, Perayre M, Berbel D, Tebe C, Riera J, Sureda A, Cisneros JM, Carratalà J.

Antimicrob Agents Chemother. 2020 Jan 27;64(2). pii: e01521-19. doi: 10.1128/AAC.01521-19. Print 2020 Jan 27.

PMID:
31712211
3.

Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.

López-Aladid R, Guiu A, Mosquera MM, López-Medrano F, Cofán F, Linares L, Torre-Cisneros J, Vidal E, Moreno A, Aguado JM, Cordero E, Martin-Gandul C, Carratalá J, Sabé N, Niubó J, Cervera C, Capón A, Cervilla A, Santos M, Bodro M, Muñoz P, Fariñas MC, Antón A, Aranzamendi M, Montejo M, Pérez-Romero P, Len O, Marcos MÁ.

PLoS One. 2019 Jul 18;14(7):e0219701. doi: 10.1371/journal.pone.0219701. eCollection 2019.

4.

Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study.

Molina-Ortega A, Martín-Gandul C, Mena-Romo JD, Rodríguez-Hernández MJ, Suñer M, Bernal C, Sánchez M, Sánchez-Céspedes J, Pérez Romero P, Cordero E.

Clin Microbiol Infect. 2019 Jun;25(6):753-758. doi: 10.1016/j.cmi.2018.09.019. Epub 2018 Oct 5.

PMID:
30292792
5.

Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).

Gudiol C, Nicolae S, Royo-Cebrecos C, Aguilar-Guisado M, Montero I, Martín-Gandul C, Perayre M, Berbel D, Encuentra M, Arnan M, Cisneros-Herreros JM, Carratalà J.

Trials. 2018 May 2;19(1):264. doi: 10.1186/s13063-018-2647-y.

6.

Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study.

Martín-Gandul C, Pérez-Romero P, Mena-Romo D, Molina-Ortega A, González-Roncero FM, Suñer M, Bernal G, Cordero E; Spanish Network for Research in Infectious Diseases (REIPI).

Transpl Infect Dis. 2018 Jun;20(3):e12883. doi: 10.1111/tid.12883. Epub 2018 Apr 16.

PMID:
29570917
7.

CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.

Mena-Romo JD, Pérez Romero P, Martín-Gandul C, Gentil MÁ, Suárez-Artacho G, Lage E, Sánchez M, Cordero E.

J Infect. 2017 Oct;75(4):336-345. doi: 10.1016/j.jinf.2017.05.020. Epub 2017 Jun 13.

PMID:
28599954
8.

Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance.

López-Aladid R, Guiu A, Sanclemente G, López-Medrano F, Cofán F, Mosquera MM, Torre-Cisneros J, Vidal E, Moreno A, Aguado JM, Cordero E, Martin-Gandul C, Pérez-Romero P, Carratalá J, Sabé N, Niubó J, Cervera C, Cervilla A, Bodro M, Muñoz P, Fariñas C, Codina MG, Aranzamendi M, Montejo M, Len O, Marcos MA; Group for Study of Infection in Transplantation of the Spanish Society of Infectious Diseases Clinical Microbiology GESITRA-SEIMC Spanish Network for Research in Infectious.

J Clin Virol. 2017 May;90:57-63. doi: 10.1016/j.jcv.2017.03.014. Epub 2017 Mar 21.

9.

Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.

Martin-Gandul C, Stampf S, Héquet D, Mueller NJ, Cusini A, van Delden C, Khanna N, Boggian K, Hirzel C, Soccal P, Hirsch HH, Pascual M, Meylan P, Manuel O; Swiss Transplant Cohort Study (STCS).

Am J Transplant. 2017 Jul;17(7):1813-1822. doi: 10.1111/ajt.14192. Epub 2017 Feb 2.

10.

Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study.

Martín-Gandul C, Mayorga-Buiza MJ, Castillo-Ojeda E, Gómez-Gómez MJ, Rivero-Garvía M, Gil-Navarro MV, Márquez-Rivas FJ, Jiménez-Mejías ME.

Acta Neurochir (Wien). 2016 Oct;158(10):1837-43. doi: 10.1007/s00701-016-2915-0. Epub 2016 Aug 13.

PMID:
27520361
11.

Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8(+) T-cell differentiation in high-risk solid organ transplant patients.

Cantisán S, Páez-Vega A, Pérez-Romero P, Montejo M, Cordero E, Gracia-Ahufinger I, Martín-Gandul C, Maruri N, Aguado R, Solana R, Torre-Cisneros J; Spanish Network for Research in Infectious Diseases (REIPI).

Antiviral Res. 2016 Aug;132:244-51. doi: 10.1016/j.antiviral.2016.06.012. Epub 2016 Jul 1.

PMID:
27378225
12.

Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation.

Blanco-Lobo P, Cordero E, Martín-Gandul C, Gentil MA, Suárez-Artacho G, Sobrino M, Aznar J, Pérez-Romero P.

J Infect. 2016 May;72(5):597-607. doi: 10.1016/j.jinf.2016.02.008. Epub 2016 Feb 24.

PMID:
26920791
13.

The Impact of Infection on Chronic Allograft Dysfunction and Allograft Survival After Solid Organ Transplantation.

Martin-Gandul C, Mueller NJ, Pascual M, Manuel O.

Am J Transplant. 2015 Dec;15(12):3024-40. doi: 10.1111/ajt.13486. Epub 2015 Oct 16. Review.

14.

Clinical impact of neutropenia related with the preemptive therapy of CMV infection in solid organ transplant recipients.

Martín-Gandul C, Pérez-Romero P, González-Roncero FM, Berdaguer S, Gómez MA, Lage E, Sánchez M, Cisneros JM, Cordero E; Spanish Network for Research in Infectious Diseases REIPI.

J Infect. 2014 Nov;69(5):500-6. doi: 10.1016/j.jinf.2014.07.001. Epub 2014 Jul 16.

PMID:
25037022
15.

Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy.

Martín-Gandul C, Pérez-Romero P, Blanco-Lobo P, Benmarzouk-Hidalgo OJ, Sánchez M, Gentil MA, Bernal C, Sobrino JM, Rodríguez-Hernández MJ, Cordero E; Spanish Network for Research in Infectious Diseases (REIPI).

Transpl Int. 2014 Oct;27(10):1060-8. doi: 10.1111/tri.12378. Epub 2014 Aug 20.

16.

Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals.

Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Martín-Gandul C, López-Medrano F, de Gopegui ER, Ramón Blanco J, García-Pardo G, Calbo E, Horcajada JP, Granados A, Jover-Sáenz A, Dueñas C, Pujol M; REIPI/GEIM Study Groups.

Clin Microbiol Infect. 2014 Apr;20(4):361-7. doi: 10.1111/1469-0691.12330. Epub 2013 Aug 28.

17.

Use of high-dose ganciclovir for the treatment of cytomegalovirus replication in solid organ transplant patients with ganciclovir resistance-inducing mutations.

Gracia-Ahufinger I, Gutiérrez-Aroca J, Cordero E, Vidal E, Cantisán S, del Castillo D, Martín-Gandul C, Rivero A, Torre-Cisneros J.

Transplantation. 2013 Apr 27;95(8):1015-20. doi: 10.1097/TP.0b013e31828555ac.

PMID:
23407543
18.

Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection.

Martín-Gandul C, Pérez-Romero P, Sánchez M, Bernal G, Suárez G, Sobrino M, Merino L, Cisneros JM, Cordero E; Spanish Network for Research in Infectious Diseases.

J Clin Virol. 2013 Jan;56(1):13-8. doi: 10.1016/j.jcv.2012.09.017. Epub 2012 Nov 3.

PMID:
23131346
19.

More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates.

Martín-Gandul C, García-Cabrera E, Castillo-Ojeda E, Jiménez-Mejías ME.

J Antimicrob Chemother. 2012 Apr;67(4):1048-9. doi: 10.1093/jac/dkr556. Epub 2011 Dec 29. No abstract available.

PMID:
22207597
20.

Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment.

Benmarzouk-Hidalgo OJ, Cisneros JM, Cordero E, Martín-Peña A, Sanchez B, Martin-Gandul C, Gentil MA, Gomez-Bravo MA, Lage E, Perez-Romero P.

Transplantation. 2011 Apr 27;91(8):927-33. doi: 10.1097/TP.0b013e3182115ba2.

PMID:
21358366

Supplemental Content

Loading ...
Support Center